More Business Wire
View Older Stories View Newer Stories-
Evolv Technology to Host Investor Day on June 9, 2026
-
PathSolutions Launches TotalView AI, Delivering Real-Time Root-Cause Analysis Powered by Complete On-Prem Network Data
-
Natixis Investment Managers and Loomis Sayles Collaborate on Launch of Credit Income Opportunities Interval Fund
-
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
-
Constellation Energy Corporation Announces Pricing of Secondary Public Offering of Common Stock
-
ISS and Egan-Jones Join Glass Lewis to Recommend ECAT Shareholders Vote to Support ECAT Board Nominees
-
The Redesign Group Named Dell Technologies’ 2026 North American Data Center Partner of the Year
-
BRW Announces $0.085 Dividend
-
SABA Announces $0.058 Dividend
-
Nextpower Files Patent Lawsuit Against GameChange Solar
-
Hilton Launches Undergraduate by Hilton, Accelerating Lifestyle Portfolio Growth
-
OSI Systems Receives $19 Million Order to Support Deployment of Non-Intrusive Inspection Solutions
-
Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
-
StubHub Named Official Open Distribution Partner of Danny Wimmer Presents
-
Everus Announces Promotions of Behring, Hendricks
-
Deepgram Delivers Private Voice AI to Regulated Industries with On-Premises Deployments Powered by Fortanix Confidential AI and NVIDIA Confidential Computing
-
Cintas Earns Spot on Forbes America’s Best Employers for New Grads 2026 List
-
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026
-
Qlik Survey: U.S. Workers Plan to Watch the World Cup on the Clock and Use AI to Catch Up
-
Hyliion’s KARNO™ Power Module Named 2026 Most Valuable Product by Consulting-Specifying Engineer
-
Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis
-
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
-
Brera Holdings PLC (NASDAQ: SLMT) (d/b/a Solmate Infrastructure) Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearing Cancelled
-
Amprius Sets June 2026 Events Schedule
-
Janus Living Announces Launch of Public Offering of Class A-1 Common Stock
-
Mantis Innovation Launches Next‑Generation Perform Platform to Elevate Facility and Energy Decision‑Making
-
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders
-
Avenzo Therapeutics Presents Updated Results from the Phase 1/2 Study of AVZO-021, a Potentially Differentiated CDK2 Inhibitor, at the 2026 American Society of Clinical Oncology Annual Meeting
-
SmartBear Advances TestComplete with Vision AI, Enabling Automated Testing for Highly Critical Visual Applications
-
TaoWeave Expands Into Physical AI With Investment in Manako Labs and North American Commercialization Rights
-
Optimum Subsidiary Announces Launch of Tender Offer for Shares of Optimum’s Class A Common Stock
-
Viking Names Newest Ocean Ship in Italy
-
Cinemark Reaches All-Time High Domestic Box Office for May
-
PagerDuty to Present at the Bank of America Securities 2026 Global Technology Conference
-
Mediacom Communications Honors John Pascarelli Upon His Retirement After 28 Years of Service
-
IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolization-eligible unresectable liver cancer in
-
Sumitomo Pharma America Presents First Clinical Data for SMP-3124LP, an Investigational PEGylated Liposome CHK1 Inhibitor, at ASCO 2026
-
CoreWeave Completes Industry-First Bring-Up and Validation of NVIDIA Vera Rubin NVL72
-
Yamaha Motor Finance Corporation, U.S.A., Completes $400 Million Asset-Backed Securitization
-
UL Solutions to Attend Upcoming Investor Conferences
-
Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer
-
Falabella Selects Topsort as Strategic Partner to Scale Its Retail Media Offering Through Fmedia
-
Oscilloquartz delivers assured timing for mission-critical harsh environments with ruggedSync™ Series OSA 5510
-
Single Blood Test Simultaneously Captures Immune, Stromal, and Tumor Signals Linked to Immunotherapy Response and Resistance in Sarcoma
-
Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
-
Rocket Mortgage, Nation’s #1 Mortgage Lender, Adopts VantageScore 4.0 Credit Score for Mortgages
-
Post Oak Energy Capital Announces Sale of Switchgrass E&P Holdco, LLC
-
Venu Holding Corporation to Join Russell 3000 Index
-
Shake Shack to Participate in June Investor Conferences
-
Palladyne AI Appoints Retired Lieutenant General Sean Bernabe and Retired Brigadier General Gwyn Armfield to Defense Advisory Board
